LOWDELL MARK WILLIAM (Chief Scientific Officer) exercised options at INMUNE BIO, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 7/7/2026ACC: 0001213900-26-075737
Officer10% Owner· Chief Scientific Officer
0.00
Net shares
Net seller
$10.1K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
7.21K acquired · 7.21K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+7.21K
Price / share
$1.40
Trade value
$10.10K
% of position
0.5%
7/2/2026
1.51M→1.52M
Total
Net shares
+7.21K
Net value
$10.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/2/2026 | M · Option Exercise | +7.21K | $1.40 | $10.10K | 0.5% | 1.51M | 1.52M |
| Total | +7.21K | $10.10K | ||||||
Derivative Transactions1
Common Stock Purchase Warrant
Direct
Converts to
Common Stock
7.21K shares
Shares
−7.21K
Strike price
1.40
Held after
7.21K
Exercisable
—
7/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Common Stock Purchase Warrant Direct | Common Stock7.21K shares | 7/2/2026 | X · X | −7.21K | 1.40 | — | 7.21K |